Birdwatch Note
2025-04-17 22:24:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Tippens was actually participating in a clinical trial for Keytruda (immunotherapy drug) at MD Anderson Cancer Center when he experienced his recovery. His improvement was likely attributable to this immunotherapy treatment rather than fenbendazole alone: https://pmc.ncbi.nlm.nih.gov/articles/PMC9650234/ https://www.logicallyfacts.com/en/fact-check/false-no-evidence-to-prove-animal-deworming-drug-fenbendazole-can-cure-cancer https://pubmed.ncbi.nlm.nih.gov/23393324/ Facts: https://www.politifact.com/factchecks/2023/feb/20/facebook-posts/no-proof-dog-deworming-drug-fenbendazole-can-cure/ https://factcheck.afp.com/doc.afp.com.33DM73U https://fullfact.org/health/fenbendazole-no-evidence-cancer-cure/ https://healthfeedback.org/claimreview/lack-clinical-evidence-dog-dewormer-fenbendazole-cures-cancer/
Written by 8E0782E7F593AE43DE132F9A686B9623FE5078AF96C0655960B8BBFA4E740320
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1912921585297604755
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1912995734858629227
- noteId - 1912995734858629227
- participantId -
- noteAuthorParticipantId - 8E0782E7F593AE43DE132F9A686B9623FE5078AF96C0655960B8BBFA4E740320 Participant Details
- createdAtMillis - 1744928699589
- tweetId - 1912921585297604755
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Tippens was actually participating in a clinical trial for Keytruda (immunotherapy drug) at MD Anderson Cancer Center when he experienced his recovery. His improvement was likely attributable to this immunotherapy treatment rather than fenbendazole alone: https://pmc.ncbi.nlm.nih.gov/articles/PMC9650234/ https://www.logicallyfacts.com/en/fact-check/false-no-evidence-to-prove-animal-deworming-drug-fenbendazole-can-cure-cancer https://pubmed.ncbi.nlm.nih.gov/23393324/ Facts: https://www.politifact.com/factchecks/2023/feb/20/facebook-posts/no-proof-dog-deworming-drug-fenbendazole-can-cure/ https://factcheck.afp.com/doc.afp.com.33DM73U https://fullfact.org/health/fenbendazole-no-evidence-cancer-cure/ https://healthfeedback.org/claimreview/lack-clinical-evidence-dog-dewormer-fenbendazole-cures-cancer/
Note Ratings
| rated at | rated by | |
| 2025-04-17 18:57:52 -0400 | Rating Details | |
| 2025-04-17 18:42:51 -0400 | Rating Details | |
| 2025-04-17 20:14:24 -0400 | Rating Details | |
| 2025-04-17 19:56:22 -0400 | Rating Details | |
| 2025-04-17 19:08:31 -0400 | Rating Details | |
| 2025-04-18 08:41:56 -0400 | Rating Details | |
| 2025-04-17 19:50:13 -0400 | Rating Details | |
| 2025-04-17 19:09:08 -0400 | Rating Details | |
| 2025-04-18 14:06:44 -0400 | Rating Details | |
| 2025-04-17 18:54:22 -0400 | Rating Details | |
| 2025-04-17 18:54:07 -0400 | Rating Details | |
| 2025-04-17 18:40:26 -0400 | Rating Details | |
| 2025-04-17 19:48:27 -0400 | Rating Details | |
| 2025-04-17 18:37:22 -0400 | Rating Details | |
| 2025-04-17 20:32:17 -0400 | Rating Details | |
| 2025-04-17 18:41:56 -0400 | Rating Details | |
| 2025-04-17 21:24:33 -0400 | Rating Details | |
| 2025-04-17 19:08:47 -0400 | Rating Details | |
| 2025-04-17 18:42:54 -0400 | Rating Details | |
| 2025-04-17 18:37:10 -0400 | Rating Details | |
| 2025-04-17 22:20:48 -0400 | Rating Details | |
| 2025-04-17 22:07:11 -0400 | Rating Details | |
| 2025-04-17 19:41:26 -0400 | Rating Details | |
| 2025-04-17 19:27:51 -0400 | Rating Details | |
| 2025-04-17 18:58:02 -0400 | Rating Details | |
| 2025-04-17 22:50:15 -0400 | Rating Details | |
| 2025-04-17 19:29:20 -0400 | Rating Details | |
| 2025-04-17 19:19:21 -0400 | Rating Details | |
| 2025-04-17 21:03:00 -0400 | Rating Details | |
| 2025-04-17 20:28:36 -0400 | Rating Details | |
| 2025-04-17 18:39:54 -0400 | Rating Details | |
| 2025-04-17 18:58:51 -0400 | Rating Details | |
| 2025-04-18 09:27:58 -0400 | Rating Details | |
| 2025-04-17 21:51:22 -0400 | Rating Details | |
| 2025-04-17 20:50:03 -0400 | Rating Details | |
| 2025-04-18 09:43:09 -0400 | Rating Details | |
| 2025-04-17 20:27:02 -0400 | Rating Details |